Matisse Capital Forma Therapeutics Holdings, Inc. Transaction History

Matisse Capital

  • $205 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 04, 2022
SELL
$13.6 - $24.89 $138,720 - $253,878
-10,200 Closed
0 $0
Q3 2021

Nov 08, 2021
SELL
$21.22 - $25.7 $6,366 - $7,710
-300 Reduced 2.86%
10,200 $237,000
Q2 2021

Aug 11, 2021
BUY
$22.86 - $30.95 $240,030 - $324,975
10,500 New
10,500 $261,000

Others Institutions Holding FMTX

# of Institutions
2
Shares Held
26.5K
Call Options Held
0
Put Options Held
0
View Full List

About Forma Therapeutics Holdings, Inc.

FMTX Quotes by TradingView
  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track This Portfolio

Track Matisse Capital Portfolio

Follow Matisse Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Matisse Capital, based on Form 13F filings with the SEC.

News

Stay updated on Matisse Capital with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email